JTI Launches Limited Edition Ploom X Advanced in South Korea, Priced at Around $50

Jul.01.2025

On July 1, JTI Korea launched the Ploom X Advanced Limited Edition Ora Ito Red, a red heat-not-burn device developed in collaboration with designer Ora Ito. The standalone device is priced at approximately $50.

Key Points:

·New Product Launch: JTI Korea, the international company of Japan Tobacco, has introduced its second limited edition product in South Korea, the "Ploom X Advanced Limited Edition Ora Ito Red".

·Design features: Designed by French designer Ora Ito, utilizing vibrant red color scheme to embody minimalist aesthetic.

·Sales Information: Starting from July 1st, the product will be exclusively available on the official website, priced at 69,000 Korean Won (approximately 50 USD) for the single item and 77,000 Korean Won (approximately 55 USD) for the set.

【2Firsts news flash】According to Newstap, on July 1st, JTI Korea announced the launch of their second limited edition product, the "Ploom X Advanced Limited Edition Ora Ito Red," in South Korea.

This new product is the second limited edition released after the launch of "Ploom X Advanced Limited Edition Aqua Halo" in May, and it was created in collaboration with the world-renowned designer Ora Ito. Ora Ito, born in France, has gained fame over the past 20 years through collaborations with numerous global brands and was selected by Forbes in 2021 as one of the "World's Most Outstanding Designers.

The product will be exclusively available for sale on the official website Ploom.co.kr starting from July 1st. The suggested retail price is 69,000 Korean won (approximately $50) for a single device and 77,000 Korean won (approximately $55) for a set.

References:

[1] JTI 韩国与 Ora Ito 合作限量版“Plume X Advanced Ora Ito Red”发布

Also Read:

[1] South Korea’s KT&G Pledges $290,000 to Support Tobacco Farmers’ Health Checks and Training Programs

[2] Philip Morris Korea Launches New ILUMA-Compatible HeatStick “Teria Twilight Pearl” on June 26

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn

Notice

1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

Copyright

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

AI Assistance Disclaimer

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Interpreting FDA’s on! PLUS Authorization: What the Agency’s Press Release Reveals About Its Nicotine Pouch Review Model

The U.S. Food and Drug Administration has confirmed that six on! PLUS nicotine pouch products have received Marketing Granted Orders (MGO) through the PMTA pathway. The authorizations were completed under the agency’s nicotine pouch review pilot program in “record time,” with the FDA citing lower levels of harmful constituents while stressing that the decision applies only to the specified products and does not mean they are safe or FDA approved.

Regulations

Dec.20

BAT plans to sell its stake in ITC Hotels, using proceeds to reduce debt

British American Tobacco (BAT) plans to sell all or part of its stake in ITC Hotels via an accelerated bookbuild, with the sale size expected to be up to 15.3% of the company’s shares. The company says the proceeds will be used to reduce debt and bring its leverage back within the target range.

Dec.05 by 2FIRSTS.ai

Mexico’s ENCODAT 2025 finds smoking rate falls as vaping rises

Results from Mexico’s ENCODAT 2025 indicate a structural shift in tobacco and nicotine use: past-month combustible tobacco use among the general population (ages 12–65) declined to 15.1%, down from 17.6% in 2016, while past-month e-cigarette use increased to 2.6%, up from 1.1%.

Dec.25 by 2FIRSTS.ai

2Firsts Co-Founder and CEO Alan Zhao Speaks at PouchEX 2025: Highlighting China’s Critical Role in the Global Nicotine Pouch Industry